NYSE:LFC - China Life Insurance Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00 %
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$10.07
▼ -0.16 (-1.56%)
1 month | 3 months | 12 months
Get New China Life Insurance Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for LFC and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for LFC

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for China Life Insurance in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $10.07.

N/A

The current consensus among 0 polled investment analysts is to n/a stock in China Life Insurance. This rating has held steady since December 2020, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 3 buy ratings
  • 3 hold ratings
  • 0 sell ratings
12/21/2019
  • 0 strong buy ratings
  • 3 buy ratings
  • 1 hold ratings
  • 0 sell ratings
3/20/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
6/18/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
9/16/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/15/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/15/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/14/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/13/2021

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
1/6/2020CLSAUpgradeUnderperform ➝ OutperformLow
i
10/30/2019CitigroupUpgradeReduce ➝ Hold$17.90 ➝ $20.30Low
i
6/9/2019The Goldman Sachs GroupUpgradeSell ➝ BuyMedium
i
5/30/2019JPMorgan Chase & Co.UpgradeNeutral ➝ OverweightLow
i
3/5/2019The Goldman Sachs GroupDowngradeNeutral ➝ SellLow
i
1/29/2019Nomura SecuritiesDowngradeBuy ➝ NeutralHigh
i
1/22/2019Bank of AmericaUpgradeNeutral ➝ BuyMedium
i
1/22/2019HSBCDowngradeBuy ➝ HoldHigh
i
12/18/2018The Goldman Sachs GroupUpgradeSell ➝ NeutralLow
i
12/7/2018Nomura SecuritiesDowngradeNeutral ➝ ReduceLow
i
11/26/2018UBS GroupDowngradeBuy ➝ NeutralMedium
i
11/20/2018Deutsche Bank AktiengesellschaftUpgradeBuyLow
i
10/29/2018Sanford C. BernsteinDowngradeOutperform ➝ Market PerformHigh
i
10/5/2018Nomura SecuritiesDowngradeBuy ➝ NeutralLow
i
9/6/2018HSBCDowngradeHold ➝ ReduceLow
i
8/21/2018Nomura SecuritiesUpgradeNeutral ➝ BuyLow
i
8/9/2018HSBCUpgradeReduce ➝ HoldMedium
i
8/3/2018JPMorgan Chase & Co.DowngradeOverweight ➝ NeutralLow
i
7/25/2018Morgan StanleyUpgradeUnderweight ➝ Equal WeightLow
i
5/10/2018The Goldman Sachs GroupDowngradeNeutral ➝ SellMedium
i
4/24/2018MacquarieUpgradeNeutral ➝ Outperform$13.49 ➝ $13.85Low
i
4/20/2018Nomura SecuritiesUpgradeNeutral ➝ BuyLow
i
4/4/2018HSBCUpgradeHold ➝ BuyLow
i
2/2/2018Nomura SecuritiesUpgradeReduce ➝ NeutralLow
i
1/8/2018Sanford C. BernsteinUpgradeMarket Perform ➝ OutperformLow
i
1/4/2018Credit Suisse GroupDowngradeNeutral ➝ UnderperformMedium
i
1/4/2018Deutsche Bank AktiengesellschaftDowngradeBuy ➝ HoldMedium
i
12/13/2017The Goldman Sachs GroupDowngradeBuy ➝ NeutralLow
i
12/5/2017UBS GroupUpgradeNeutral ➝ BuyLow
i
8/28/2017Daiwa Capital MarketsUpgradeBuyLow
i
Rating by Leon Qi at Daiwa Capital Markets
8/25/2017Bank of AmericaUpgradeNeutral ➝ BuyHigh
i
8/25/2017Credit Suisse GroupUpgradeUnderperform ➝ NeutralHigh
i
8/17/2017Sanford C. BernsteinDowngradeOutperform ➝ Market PerformHigh
i
8/16/2017The Goldman Sachs GroupDowngradeConviction-Buy ➝ BuyLow
i
4/25/2017Bank of AmericaDowngradeBuy ➝ NeutralHigh
i
3/24/2017CitigroupUpgradeSell ➝ NeutralLow
i
2/21/2017CitigroupUpgradeNeutral ➝ BuyN/A
i
1/18/2017Credit Suisse GroupUpgradeNeutral ➝ OutperformN/A
i
1/5/2017Daiwa Capital MarketsUpgradeHold ➝ OutperformN/A
i
12/5/2016UBS GroupDowngradeBuy ➝ NeutralN/A
i
11/23/2016The Goldman Sachs GroupUpgradeBuy ➝ Conviction-BuyN/A
i
9/29/2016Morgan StanleyDowngradeOverweight ➝ Equal WeightN/A
i
7/18/2016UBS GroupUpgradeNeutral ➝ BuyN/A
i
(Data available from 6/14/2016 forward)
China Life Insurance logo
China Life Insurance Company Limited, together with its subsidiaries, operates as a life insurance company in the People's Republic of China. It operates in four segments: Life Insurance Business, Health Insurance Business, Accident Insurance Business, and Other Businesses. The company offers individual and group life, annuity products, accident, and health insurance products. It is also involved in the third-party asset management, annuity funds, fund management, investment management, pension security, occupational pension, reinsurance, and health management businesses. China Life Insurance Company Limited sells its products through agents, direct sales representatives, and dedicated and non-dedicated agencies. The company was founded in 1949 and is based in Beijing, the People's Republic of China. China Life Insurance Company Limited is a subsidiary of China Life Insurance (Group) Company Limited.
Read More

Today's Range

Now: $10.07
$10.07
$10.19

50 Day Range

MA: $10.31
$10.04
$10.77

52 Week Range

Now: $10.07
$9.94
$13.63

Volume

651,400 shs

Average Volume

571,576 shs

Market Capitalization

$56.93 billion

P/E Ratio

6.22

Dividend Yield

4.37%

Beta

1.07

Frequently Asked Questions

What sell-side analysts currently cover shares of China Life Insurance?

The following Wall Street analysts have issued research reports on China Life Insurance in the last twelve months: Zacks Investment Research.
View the latest analyst ratings for LFC.

What is the current price target for China Life Insurance?

0 Wall Street analysts have set twelve-month price targets for China Life Insurance in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for China Life Insurance in the next year.
View the latest price targets for LFC.

What is the current consensus analyst rating for China Life Insurance?

China Life Insurance currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for LFC.

What other companies compete with China Life Insurance?

How do I contact China Life Insurance's investor relations team?

China Life Insurance's physical mailing address is 12F CHINA LIFE PLAZA A NO.16 FINANCIAL STREET XICHENG DISTRICT, BEIJING F4, 100033. The financial services provider's listed phone number is 86-10-6363-1191 and its investor relations email address is [email protected] The official website for China Life Insurance is www.e-chinalife.com.